Home > Healthcare > Medical Devices > Diagnostic Devices > Cardiac Biomarkers Market
Cardiac Biomarkers Market Share
- Report ID: GMI7121
- Published Date: Oct 2023
- Report Format: PDF
Cardiac Biomarkers Market Share
The cardiac biomarkers industry is consolidated, with major players such as Abbott, Roche dominating the market. These companies are focused on continuous product innovation to secure a significant market share. For instance, in 2021, Roche has unveiled a set of five new proposed applications for two pivotal cardiac biomarkers, utilizing the Elecsys technology: the N-terminal pro-brain natriuretic peptide test and high-sensitive cardiac troponin T. These well-established biomarkers have demonstrated their efficacy in aiding the management of cardiovascular diseases and can assist healthcare professionals in the diagnosis of heart attacks and the improved management of heart failure. The introduction of such products can certainly be advantageous for the company
.
Some of the eminent market participants operating in the cardiac biomarkers industry include:
- Abbott Diagnostics
- Roche Diagnostics
- Siemens Healthineers
- Beckman Coulter
- Bio-Rad Laboratories
- Ortho Clinical Diagnostics
- Randox Laboratories
- Quidel Corporation
- Radiometer
- Tosoh Corporation
- Meso Scale Diagnostics (MSD)
- Thermo Fisher Scientific
- Luminex Corporation
- Trinity Biotech
- Biomerieux
Frequently Asked Questions (FAQ) :
Cardiac Biomarkers Market Scope
